Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180096
Status:
COMPLETED
Last Update Posted:
2023-12-28
First Post:
2023-12-12
Brief Title:
Bioequivalence Study of Riociguat 25 mg Film Coated Tablets and Adempas Riociguat 25 mg Film Coated Tablets
Sponsor:
Humanis Saglık Anonim Sirketi
Organization:
Humanis Saglık Anonim Sirketi
Study Overview
Official Title:
Single Dose Oral Bioequivalence Study of Riociguat 25 mg Film Coated Tablets and Adempas Riociguat 25 mg Filmtabletten Film Coated Tablets in Healthy Adult Male Subjects Under Fasting Conditions
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Single dose oral bioequivalence study of Riociguat 25 mg film coated tablets and Adempas Riociguat 25 mg Filmtabletten film coated tablets in healthy adult male subjects under fasting conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None